Recurrent or primary metastatic cervical cancer: current and future treatments

Despite screening programs for early detection and the approval of human papillomavirus vaccines, around 6% of women with cervical cancer (CC) are discovered with primary metastatic disease. Moreover, one-third of the patients receiving chemoradiation followed by brachytherapy for locally advanced d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gennigens, C., Jerusalem, G., Lapaille, L., De Cuypere, M., Streel, S., Kridelka, F., Ray-Coquard, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588874/
https://www.ncbi.nlm.nih.gov/pubmed/36108558
http://dx.doi.org/10.1016/j.esmoop.2022.100579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588874/
https://www.ncbi.nlm.nih.gov/pubmed/36108558
http://dx.doi.org/10.1016/j.esmoop.2022.100579

Ejemplares similares